JPRN-jRCT2080221488招募中2 期
A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects are man or women >20 years of age, who have low HDL-C or high LDL-C without clinical manifestation of coronary heart disease.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
A Study of LY2484595 in Japanese SubjectsDyslipidemiasNCT01375075Eli Lilly and Company165
未知
1 期
A Phase 1 Study of LY2584702 in Japanese Patients with Solid TumorsCancerJPRN-jRCT2080221292Eli Lilly Japan K.K.
未知
1 期
A Phase 1 Study of LY2875358 in Japanese Patients With Advanced MalignanciesSolid Tumors, LymphomaJPRN-jRCT2080221810Eli Lilly Japan K.K.
已完成
1 期
A Phase 1 Study of LY2835219 in Japanese Patients with Advanced Cancereoplasm Metastasis, LymphomaJPRN-jRCT2080222332Eli Lilly Japan K.K.
未知
1 期
A Phase 1 Study of LY2940680 in Japanese Patients with Advanced Solid Tumorseoplasm MetastasisJPRN-jRCT2080222179Eli Lilly Japan K.K.